Status:
COMPLETED
Treatment of Patients With Idiopathic Membranous Nephropathy
Lead Sponsor:
Radboud University Medical Center
Conditions:
Glomerulonephritis, Membranous
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
Patients with idiopathic membranous nephropathy at risk for renal failure can be identified in an early stage by measuring urinary low molecular weight proteins and urinary immunoglobulin G (IgG). Thi...
Detailed Description
Inclusion Criteria: * patients with idiopathic membranous nephropathy * nephrotic syndrome * normal renal function (serum creatinine \[Screat\] \< 1.5 mg/dl) * elevated urinary beta2-microglobulin an...
Eligibility Criteria
Inclusion
- Idiopathic membranous nephropathy
- Serum creatinine \< 1.5 mg/dl
- Nephrotic syndrome
Exclusion
- Infection
- Instable angina
- Systemic disease
- Pregnancy
- Renal vein thrombosis
- Prior therapy with immunosuppressant agents
- Liver dysfunction
- Use of nonsteroidal anti-inflammatory drugs (NSAIDs)
Key Trial Info
Start Date :
July 1 1997
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT00135954
Start Date
July 1 1997
End Date
July 1 2008
Last Update
January 28 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Nephrology Radboud University Nijmegen Medical Centre
Nijmegen, Netherlands, 6500 HB